nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Anaemia—Docetaxel—stomach cancer	0.00102	0.0011	CcSEcCtD
Remifentanil—Tremor—Capecitabine—stomach cancer	0.000999	0.00108	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—stomach cancer	0.000999	0.00108	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—stomach cancer	0.000997	0.00108	CcSEcCtD
Remifentanil—Urticaria—Fluorouracil—stomach cancer	0.00099	0.00107	CcSEcCtD
Remifentanil—Syncope—Docetaxel—stomach cancer	0.000988	0.00107	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—stomach cancer	0.000987	0.00107	CcSEcCtD
Remifentanil—Anaemia—Capecitabine—stomach cancer	0.000986	0.00106	CcSEcCtD
Remifentanil—Body temperature increased—Fluorouracil—stomach cancer	0.000985	0.00106	CcSEcCtD
Remifentanil—Sweating—Methotrexate—stomach cancer	0.000974	0.00105	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—stomach cancer	0.000969	0.00105	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—stomach cancer	0.000968	0.00105	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—stomach cancer	0.000962	0.00104	CcSEcCtD
Remifentanil—Cough—Docetaxel—stomach cancer	0.000961	0.00104	CcSEcCtD
Remifentanil—Hypersensitivity—Irinotecan—stomach cancer	0.000958	0.00103	CcSEcCtD
Remifentanil—Syncope—Capecitabine—stomach cancer	0.000957	0.00103	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—stomach cancer	0.000956	0.00103	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—stomach cancer	0.000955	0.00103	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—stomach cancer	0.000951	0.00103	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—stomach cancer	0.000949	0.00102	CcSEcCtD
Remifentanil—Loss of consciousness—Capecitabine—stomach cancer	0.000938	0.00101	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—stomach cancer	0.000935	0.00101	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000931	0.00101	CcSEcCtD
Remifentanil—Cough—Capecitabine—stomach cancer	0.000931	0.001	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—stomach cancer	0.000923	0.000996	CcSEcCtD
Remifentanil—Hypertension—Capecitabine—stomach cancer	0.000921	0.000994	CcSEcCtD
Remifentanil—Hypersensitivity—Fluorouracil—stomach cancer	0.000918	0.000991	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—stomach cancer	0.000917	0.00099	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—stomach cancer	0.000917	0.00099	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—stomach cancer	0.000912	0.000985	CcSEcCtD
Remifentanil—Sweating—Epirubicin—stomach cancer	0.000912	0.000984	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—stomach cancer	0.000907	0.000979	CcSEcCtD
Remifentanil—Confusional state—Docetaxel—stomach cancer	0.000907	0.000979	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—stomach cancer	0.000905	0.000977	CcSEcCtD
Remifentanil—Anxiety—Capecitabine—stomach cancer	0.000905	0.000977	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000902	0.000974	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—stomach cancer	0.000899	0.000971	CcSEcCtD
Remifentanil—Oedema—Docetaxel—stomach cancer	0.000899	0.000971	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—stomach cancer	0.00089	0.000961	CcSEcCtD
Remifentanil—Diarrhoea—Irinotecan—stomach cancer	0.00089	0.000961	CcSEcCtD
Remifentanil—Dry mouth—Capecitabine—stomach cancer	0.000888	0.000959	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—stomach cancer	0.000885	0.000955	CcSEcCtD
Remifentanil—Shock—Docetaxel—stomach cancer	0.000885	0.000955	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—stomach cancer	0.000882	0.000952	CcSEcCtD
Remifentanil—Pruritus—Fluorouracil—stomach cancer	0.000881	0.000951	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—stomach cancer	0.00088	0.00095	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—stomach cancer	0.000879	0.000949	CcSEcCtD
Remifentanil—Confusional state—Capecitabine—stomach cancer	0.000878	0.000948	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—stomach cancer	0.000878	0.000947	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—stomach cancer	0.000873	0.000943	CcSEcCtD
Remifentanil—Oedema—Capecitabine—stomach cancer	0.000871	0.00094	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—stomach cancer	0.000869	0.000938	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—stomach cancer	0.000865	0.000934	CcSEcCtD
Remifentanil—Dizziness—Irinotecan—stomach cancer	0.00086	0.000929	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—stomach cancer	0.000858	0.000926	CcSEcCtD
Remifentanil—Shock—Capecitabine—stomach cancer	0.000856	0.000925	CcSEcCtD
Remifentanil—Nervous system disorder—Capecitabine—stomach cancer	0.000854	0.000922	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—stomach cancer	0.000854	0.000921	CcSEcCtD
Remifentanil—Diarrhoea—Fluorouracil—stomach cancer	0.000852	0.00092	CcSEcCtD
Remifentanil—Thrombocytopenia—Capecitabine—stomach cancer	0.000852	0.00092	CcSEcCtD
Remifentanil—Tachycardia—Capecitabine—stomach cancer	0.00085	0.000917	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—stomach cancer	0.000847	0.000915	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—stomach cancer	0.000847	0.000914	CcSEcCtD
Remifentanil—Skin disorder—Capecitabine—stomach cancer	0.000846	0.000913	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—stomach cancer	0.000844	0.000911	CcSEcCtD
Remifentanil—Hyperhidrosis—Capecitabine—stomach cancer	0.000842	0.000908	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—stomach cancer	0.00084	0.000907	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—stomach cancer	0.000839	0.000906	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—stomach cancer	0.000828	0.000893	CcSEcCtD
Remifentanil—Vomiting—Irinotecan—stomach cancer	0.000827	0.000893	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—stomach cancer	0.000824	0.000889	CcSEcCtD
Remifentanil—Dizziness—Fluorouracil—stomach cancer	0.000824	0.000889	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—stomach cancer	0.000823	0.000888	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—stomach cancer	0.000822	0.000887	CcSEcCtD
Remifentanil—Rash—Irinotecan—stomach cancer	0.00082	0.000885	CcSEcCtD
Remifentanil—Dermatitis—Irinotecan—stomach cancer	0.000819	0.000884	CcSEcCtD
Remifentanil—Chills—Methotrexate—stomach cancer	0.000818	0.000884	CcSEcCtD
Remifentanil—Headache—Irinotecan—stomach cancer	0.000815	0.00088	CcSEcCtD
Remifentanil—Hypotension—Capecitabine—stomach cancer	0.000813	0.000878	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—stomach cancer	0.000807	0.000872	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—stomach cancer	0.000804	0.000868	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—stomach cancer	0.000802	0.000865	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—stomach cancer	0.000799	0.000863	CcSEcCtD
Remifentanil—Erythema—Methotrexate—stomach cancer	0.000794	0.000857	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—stomach cancer	0.000794	0.000857	CcSEcCtD
Remifentanil—Flushing—Epirubicin—stomach cancer	0.000792	0.000855	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—stomach cancer	0.000792	0.000855	CcSEcCtD
Remifentanil—Vomiting—Fluorouracil—stomach cancer	0.000792	0.000855	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—stomach cancer	0.000791	0.000854	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—stomach cancer	0.00079	0.000853	CcSEcCtD
Remifentanil—Rash—Fluorouracil—stomach cancer	0.000785	0.000848	CcSEcCtD
Remifentanil—Dermatitis—Fluorouracil—stomach cancer	0.000785	0.000847	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—stomach cancer	0.000784	0.000846	CcSEcCtD
Remifentanil—Paraesthesia—Capecitabine—stomach cancer	0.000782	0.000844	CcSEcCtD
Remifentanil—Headache—Fluorouracil—stomach cancer	0.00078	0.000842	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000776	0.000838	CcSEcCtD
Remifentanil—Dyspnoea—Capecitabine—stomach cancer	0.000776	0.000838	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—stomach cancer	0.000774	0.000836	CcSEcCtD
Remifentanil—Nausea—Irinotecan—stomach cancer	0.000773	0.000834	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—stomach cancer	0.000771	0.000832	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—stomach cancer	0.000769	0.00083	CcSEcCtD
Remifentanil—Pain—Docetaxel—stomach cancer	0.000769	0.00083	CcSEcCtD
Remifentanil—Constipation—Docetaxel—stomach cancer	0.000769	0.00083	CcSEcCtD
Remifentanil—Dyspepsia—Capecitabine—stomach cancer	0.000766	0.000827	CcSEcCtD
Remifentanil—Chills—Epirubicin—stomach cancer	0.000766	0.000827	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—stomach cancer	0.000763	0.000823	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—stomach cancer	0.000761	0.000822	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000752	0.000811	CcSEcCtD
Remifentanil—Constipation—Capecitabine—stomach cancer	0.000744	0.000804	CcSEcCtD
Remifentanil—Pain—Capecitabine—stomach cancer	0.000744	0.000804	CcSEcCtD
Remifentanil—Erythema—Epirubicin—stomach cancer	0.000743	0.000802	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—stomach cancer	0.000741	0.0008	CcSEcCtD
Remifentanil—Nausea—Fluorouracil—stomach cancer	0.00074	0.000799	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—stomach cancer	0.000734	0.000792	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—stomach cancer	0.000733	0.000791	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—stomach cancer	0.000733	0.000791	CcSEcCtD
Remifentanil—Feeling abnormal—Capecitabine—stomach cancer	0.000717	0.000774	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—stomach cancer	0.000717	0.000774	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—stomach cancer	0.000713	0.00077	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—stomach cancer	0.000712	0.000768	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—stomach cancer	0.000711	0.000767	CcSEcCtD
Remifentanil—Chills—Doxorubicin—stomach cancer	0.000709	0.000765	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—stomach cancer	0.000706	0.000762	CcSEcCtD
Remifentanil—Cough—Methotrexate—stomach cancer	0.000693	0.000748	CcSEcCtD
Remifentanil—Urticaria—Capecitabine—stomach cancer	0.000692	0.000747	CcSEcCtD
Remifentanil—Body temperature increased—Capecitabine—stomach cancer	0.000688	0.000743	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—stomach cancer	0.000688	0.000743	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—stomach cancer	0.000688	0.000742	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—stomach cancer	0.000687	0.000741	CcSEcCtD
Remifentanil—Agitation—Epirubicin—stomach cancer	0.000683	0.000737	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000671	0.000725	CcSEcCtD
Remifentanil—Syncope—Epirubicin—stomach cancer	0.000666	0.000719	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—stomach cancer	0.000662	0.000715	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—stomach cancer	0.000653	0.000705	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—stomach cancer	0.000653	0.000705	CcSEcCtD
Remifentanil—Cough—Epirubicin—stomach cancer	0.000648	0.0007	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—stomach cancer	0.000648	0.0007	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—stomach cancer	0.000644	0.000695	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—stomach cancer	0.000642	0.000693	CcSEcCtD
Remifentanil—Hypersensitivity—Capecitabine—stomach cancer	0.000641	0.000692	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—stomach cancer	0.000636	0.000687	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—stomach cancer	0.000636	0.000686	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—stomach cancer	0.000636	0.000686	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—stomach cancer	0.000635	0.000685	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—stomach cancer	0.000632	0.000682	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—stomach cancer	0.00063	0.000681	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—stomach cancer	0.000629	0.00068	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000628	0.000678	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—stomach cancer	0.000626	0.000676	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—stomach cancer	0.000619	0.000668	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—stomach cancer	0.000617	0.000666	CcSEcCtD
Remifentanil—Pruritus—Capecitabine—stomach cancer	0.000616	0.000665	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—stomach cancer	0.000615	0.000664	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—stomach cancer	0.000612	0.00066	CcSEcCtD
Remifentanil—Oedema—Epirubicin—stomach cancer	0.000606	0.000655	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—stomach cancer	0.000606	0.000655	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—stomach cancer	0.000606	0.000654	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—stomach cancer	0.000604	0.000652	CcSEcCtD
Remifentanil—Cough—Doxorubicin—stomach cancer	0.0006	0.000648	CcSEcCtD
Remifentanil—Shock—Epirubicin—stomach cancer	0.000597	0.000644	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—stomach cancer	0.000596	0.000643	CcSEcCtD
Remifentanil—Diarrhoea—Capecitabine—stomach cancer	0.000596	0.000643	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—stomach cancer	0.000595	0.000642	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—stomach cancer	0.000595	0.000642	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—stomach cancer	0.000594	0.000641	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—stomach cancer	0.000594	0.000641	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—stomach cancer	0.000592	0.000639	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—stomach cancer	0.000589	0.000636	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—stomach cancer	0.000586	0.000633	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—stomach cancer	0.000583	0.00063	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—stomach cancer	0.000582	0.000628	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000581	0.000628	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—stomach cancer	0.000578	0.000624	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—stomach cancer	0.000576	0.000622	CcSEcCtD
Remifentanil—Dizziness—Capecitabine—stomach cancer	0.000576	0.000621	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—stomach cancer	0.000572	0.000618	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—stomach cancer	0.000572	0.000617	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—stomach cancer	0.00057	0.000616	CcSEcCtD
Remifentanil—Rash—Docetaxel—stomach cancer	0.000567	0.000612	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—stomach cancer	0.000567	0.000612	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—stomach cancer	0.000566	0.000611	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—stomach cancer	0.000566	0.000611	CcSEcCtD
Remifentanil—Headache—Docetaxel—stomach cancer	0.000563	0.000608	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—stomach cancer	0.000561	0.000606	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—stomach cancer	0.000561	0.000606	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000559	0.000604	CcSEcCtD
Remifentanil—Pain—Methotrexate—stomach cancer	0.000554	0.000598	CcSEcCtD
Remifentanil—Vomiting—Capecitabine—stomach cancer	0.000554	0.000598	CcSEcCtD
Remifentanil—Shock—Doxorubicin—stomach cancer	0.000552	0.000596	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—stomach cancer	0.00055	0.000594	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—stomach cancer	0.000549	0.000593	CcSEcCtD
Remifentanil—Rash—Capecitabine—stomach cancer	0.000549	0.000593	CcSEcCtD
Remifentanil—Dermatitis—Capecitabine—stomach cancer	0.000548	0.000592	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—stomach cancer	0.000548	0.000591	CcSEcCtD
Remifentanil—Headache—Capecitabine—stomach cancer	0.000545	0.000589	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—stomach cancer	0.000545	0.000588	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—stomach cancer	0.000545	0.000588	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—stomach cancer	0.000542	0.000586	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—stomach cancer	0.000541	0.000584	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—stomach cancer	0.000539	0.000582	CcSEcCtD
Remifentanil—Nausea—Docetaxel—stomach cancer	0.000534	0.000577	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—stomach cancer	0.000534	0.000576	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—stomach cancer	0.000534	0.000576	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—stomach cancer	0.000524	0.000566	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000524	0.000565	CcSEcCtD
Remifentanil—Pain—Epirubicin—stomach cancer	0.000519	0.00056	CcSEcCtD
Remifentanil—Constipation—Epirubicin—stomach cancer	0.000519	0.00056	CcSEcCtD
Remifentanil—Nausea—Capecitabine—stomach cancer	0.000517	0.000558	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—stomach cancer	0.000515	0.000556	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—stomach cancer	0.000512	0.000553	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—stomach cancer	0.000504	0.000544	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—stomach cancer	0.0005	0.00054	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—stomach cancer	0.0005	0.000539	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—stomach cancer	0.000499	0.000539	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—stomach cancer	0.000494	0.000533	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000484	0.000523	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—stomach cancer	0.000482	0.00052	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—stomach cancer	0.00048	0.000518	CcSEcCtD
Remifentanil—Pain—Doxorubicin—stomach cancer	0.00048	0.000518	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—stomach cancer	0.000479	0.000518	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—stomach cancer	0.000477	0.000515	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—stomach cancer	0.000462	0.000499	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—stomach cancer	0.000458	0.000495	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—stomach cancer	0.000447	0.000482	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—stomach cancer	0.000446	0.000481	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—stomach cancer	0.000444	0.000479	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—stomach cancer	0.000443	0.000479	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—stomach cancer	0.000429	0.000463	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—stomach cancer	0.000429	0.000463	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—stomach cancer	0.000415	0.000448	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—stomach cancer	0.000413	0.000446	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—stomach cancer	0.000412	0.000445	CcSEcCtD
Remifentanil—Rash—Methotrexate—stomach cancer	0.000409	0.000441	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—stomach cancer	0.000408	0.000441	CcSEcCtD
Remifentanil—Headache—Methotrexate—stomach cancer	0.000406	0.000438	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—stomach cancer	0.000401	0.000433	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—stomach cancer	0.000397	0.000429	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—stomach cancer	0.000386	0.000416	CcSEcCtD
Remifentanil—Nausea—Methotrexate—stomach cancer	0.000385	0.000416	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—stomach cancer	0.000384	0.000414	CcSEcCtD
Remifentanil—Rash—Epirubicin—stomach cancer	0.000382	0.000413	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—stomach cancer	0.000382	0.000412	CcSEcCtD
Remifentanil—Headache—Epirubicin—stomach cancer	0.00038	0.00041	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—stomach cancer	0.000371	0.000401	CcSEcCtD
Remifentanil—Nausea—Epirubicin—stomach cancer	0.00036	0.000389	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—stomach cancer	0.000357	0.000385	CcSEcCtD
Remifentanil—Rash—Doxorubicin—stomach cancer	0.000354	0.000382	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—stomach cancer	0.000353	0.000382	CcSEcCtD
Remifentanil—Headache—Doxorubicin—stomach cancer	0.000352	0.000379	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—stomach cancer	0.000333	0.00036	CcSEcCtD
Remifentanil—Alfentanil—ALB—stomach cancer	0.000284	0.689	CrCbGaD
Remifentanil—Pethidine—ALB—stomach cancer	0.000128	0.311	CrCbGaD
Remifentanil—OPRD1—Signaling by GPCR—ANXA1—stomach cancer	0.000125	0.0017	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR1A—stomach cancer	0.000125	0.0017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KISS1—stomach cancer	0.000121	0.00166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RNF43—stomach cancer	0.000121	0.00166	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000121	0.00165	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB1—stomach cancer	0.000121	0.00165	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ANXA1—stomach cancer	0.00012	0.00164	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—WIF1—stomach cancer	0.00012	0.00163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRH4—stomach cancer	0.00012	0.00163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AGTR2—stomach cancer	0.000118	0.0016	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB1—stomach cancer	0.000117	0.00159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2R—stomach cancer	0.000116	0.00159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR1A—stomach cancer	0.000113	0.00154	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000113	0.00154	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKAB1—stomach cancer	0.00011	0.00151	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGTR2—stomach cancer	0.000109	0.00149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ANXA1—stomach cancer	0.000109	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—WWOX—stomach cancer	0.000109	0.00148	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FST—stomach cancer	0.000108	0.00148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2R—stomach cancer	0.000108	0.00148	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB2—stomach cancer	0.000108	0.00147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KISS1—stomach cancer	0.000107	0.00145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RNF43—stomach cancer	0.000107	0.00145	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000106	0.00145	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HBEGF—stomach cancer	0.000106	0.00145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB1—stomach cancer	0.000106	0.00144	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR1A—stomach cancer	0.000105	0.00144	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAST—stomach cancer	0.000104	0.00143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RGS2—stomach cancer	0.000104	0.00143	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ANXA1—stomach cancer	0.000102	0.00139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRH4—stomach cancer	0.000101	0.00138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—WIF1—stomach cancer	0.000101	0.00138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGTR2—stomach cancer	9.93e-05	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGG—stomach cancer	9.9e-05	0.00135	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB1—stomach cancer	9.85e-05	0.00134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2R—stomach cancer	9.82e-05	0.00134	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB2—stomach cancer	9.78e-05	0.00133	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PPP2R1A—stomach cancer	9.58e-05	0.00131	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR1A—stomach cancer	9.56e-05	0.00131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKAA1—stomach cancer	9.53e-05	0.0013	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FST—stomach cancer	9.49e-05	0.0013	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB2—stomach cancer	9.44e-05	0.00129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKAB1—stomach cancer	9.32e-05	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HBEGF—stomach cancer	9.29e-05	0.00127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ANXA1—stomach cancer	9.23e-05	0.00126	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RBP4—stomach cancer	9.21e-05	0.00126	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—stomach cancer	9.2e-05	0.00126	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RGS2—stomach cancer	9.16e-05	0.00125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAST—stomach cancer	9.16e-05	0.00125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RNF43—stomach cancer	9e-05	0.00123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KISS1—stomach cancer	9e-05	0.00123	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	8.95e-05	0.00122	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB1—stomach cancer	8.94e-05	0.00122	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGG—stomach cancer	8.68e-05	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB2—stomach cancer	8.57e-05	0.00117	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PPP2R1A—stomach cancer	8.4e-05	0.00115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKAA1—stomach cancer	8.36e-05	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RBP4—stomach cancer	8.07e-05	0.0011	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—stomach cancer	8.07e-05	0.0011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FST—stomach cancer	8.02e-05	0.0011	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB2—stomach cancer	7.98e-05	0.00109	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HSPB1—stomach cancer	7.92e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGTR2—stomach cancer	7.92e-05	0.00108	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HBEGF—stomach cancer	7.85e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BMP2—stomach cancer	7.83e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2R—stomach cancer	7.83e-05	0.00107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RGS2—stomach cancer	7.74e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAST—stomach cancer	7.74e-05	0.00106	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKR1C3—stomach cancer	7.7e-05	0.00105	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR1A—stomach cancer	7.62e-05	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCB—stomach cancer	7.38e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ANXA1—stomach cancer	7.36e-05	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGG—stomach cancer	7.34e-05	0.001	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB2—stomach cancer	7.24e-05	0.000989	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB1—stomach cancer	7.13e-05	0.000973	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PPP2R1A—stomach cancer	7.1e-05	0.00097	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKAA1—stomach cancer	7.06e-05	0.000965	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HSPB1—stomach cancer	6.94e-05	0.000948	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR2—stomach cancer	6.94e-05	0.000948	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2R—stomach cancer	6.86e-05	0.000937	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BMP2—stomach cancer	6.86e-05	0.000937	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RBP4—stomach cancer	6.82e-05	0.000932	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—stomach cancer	6.82e-05	0.000931	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RPS6—stomach cancer	6.81e-05	0.00093	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKR1C3—stomach cancer	6.75e-05	0.000922	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCB—stomach cancer	6.7e-05	0.000915	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR1A—stomach cancer	6.68e-05	0.000912	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6ST—stomach cancer	6.67e-05	0.000911	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCB—stomach cancer	6.47e-05	0.000884	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ANXA1—stomach cancer	6.45e-05	0.000881	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HBEGF—stomach cancer	6.26e-05	0.000855	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB1—stomach cancer	6.25e-05	0.000853	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RPS6—stomach cancer	5.97e-05	0.000815	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6R—stomach cancer	5.95e-05	0.000813	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—RHOA—stomach cancer	5.92e-05	0.000809	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCB—stomach cancer	5.88e-05	0.000802	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HSPB1—stomach cancer	5.87e-05	0.000801	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR2—stomach cancer	5.87e-05	0.000801	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6ST—stomach cancer	5.85e-05	0.000799	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2R—stomach cancer	5.8e-05	0.000792	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BMP2—stomach cancer	5.8e-05	0.000792	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—stomach cancer	5.77e-05	0.000789	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKR1C3—stomach cancer	5.71e-05	0.000779	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PPP2R1A—stomach cancer	5.66e-05	0.000773	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1A—stomach cancer	5.65e-05	0.000771	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HBEGF—stomach cancer	5.49e-05	0.000749	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCB—stomach cancer	5.47e-05	0.000747	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ANXA1—stomach cancer	5.45e-05	0.000745	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RHOA—stomach cancer	5.38e-05	0.000734	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB1—stomach cancer	5.28e-05	0.000721	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SMAD4—stomach cancer	5.25e-05	0.000718	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6R—stomach cancer	5.22e-05	0.000713	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—stomach cancer	5.2e-05	0.00071	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—RHOA—stomach cancer	5.19e-05	0.000709	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—stomach cancer	5.06e-05	0.000692	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RPS6—stomach cancer	5.05e-05	0.000689	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FYN—stomach cancer	4.99e-05	0.000681	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCB—stomach cancer	4.97e-05	0.000678	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP2R1A—stomach cancer	4.96e-05	0.000678	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6ST—stomach cancer	4.95e-05	0.000675	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—stomach cancer	4.72e-05	0.000645	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RHOA—stomach cancer	4.72e-05	0.000644	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR2—stomach cancer	4.68e-05	0.00064	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HBEGF—stomach cancer	4.64e-05	0.000633	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SMAD4—stomach cancer	4.61e-05	0.000629	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—stomach cancer	4.56e-05	0.000623	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6R—stomach cancer	4.41e-05	0.000603	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RHOA—stomach cancer	4.39e-05	0.000599	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FYN—stomach cancer	4.37e-05	0.000597	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS2—stomach cancer	4.29e-05	0.000586	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—stomach cancer	4.28e-05	0.000584	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP2R1A—stomach cancer	4.19e-05	0.000573	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—stomach cancer	4.16e-05	0.000568	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—stomach cancer	4.15e-05	0.000567	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—stomach cancer	4.14e-05	0.000565	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR2—stomach cancer	4.11e-05	0.000561	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RHOA—stomach cancer	3.99e-05	0.000544	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCB—stomach cancer	3.96e-05	0.000541	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6ST—stomach cancer	3.94e-05	0.000538	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SMAD4—stomach cancer	3.89e-05	0.000532	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—stomach cancer	3.85e-05	0.000526	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APC—stomach cancer	3.79e-05	0.000517	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS2—stomach cancer	3.76e-05	0.000514	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FYN—stomach cancer	3.7e-05	0.000505	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—stomach cancer	3.65e-05	0.000498	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—stomach cancer	3.64e-05	0.000497	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—stomach cancer	3.63e-05	0.000495	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6R—stomach cancer	3.52e-05	0.00048	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—stomach cancer	3.5e-05	0.000478	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR2—stomach cancer	3.47e-05	0.000474	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCB—stomach cancer	3.47e-05	0.000474	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6ST—stomach cancer	3.46e-05	0.000472	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK1—stomach cancer	3.45e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—stomach cancer	3.45e-05	0.000471	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APC—stomach cancer	3.32e-05	0.000454	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—stomach cancer	3.3e-05	0.00045	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—stomach cancer	3.29e-05	0.00045	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—stomach cancer	3.26e-05	0.000445	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—stomach cancer	3.18e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS2—stomach cancer	3.18e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RHOA—stomach cancer	3.18e-05	0.000434	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—stomach cancer	3.14e-05	0.000429	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6R—stomach cancer	3.08e-05	0.000421	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—stomach cancer	3.08e-05	0.000421	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—stomach cancer	3.07e-05	0.00042	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK1—stomach cancer	3.03e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—stomach cancer	3.03e-05	0.000413	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	3e-05	0.000409	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB2—stomach cancer	2.94e-05	0.000402	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCB—stomach cancer	2.93e-05	0.000401	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6ST—stomach cancer	2.92e-05	0.000399	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	2.89e-05	0.000395	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	2.89e-05	0.000394	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—stomach cancer	2.86e-05	0.00039	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APC—stomach cancer	2.81e-05	0.000383	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—stomach cancer	2.79e-05	0.000381	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RHOA—stomach cancer	2.79e-05	0.00038	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—stomach cancer	2.77e-05	0.000378	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—stomach cancer	2.76e-05	0.000377	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	2.72e-05	0.000372	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	2.69e-05	0.000367	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—stomach cancer	2.65e-05	0.000362	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	2.63e-05	0.000359	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6R—stomach cancer	2.61e-05	0.000356	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—stomach cancer	2.6e-05	0.000355	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUN—stomach cancer	2.59e-05	0.000354	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB2—stomach cancer	2.58e-05	0.000352	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	2.56e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—stomach cancer	2.56e-05	0.000349	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—stomach cancer	2.52e-05	0.000345	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	2.51e-05	0.000343	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—stomach cancer	2.45e-05	0.000335	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—stomach cancer	2.45e-05	0.000334	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	2.44e-05	0.000334	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	2.44e-05	0.000333	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—stomach cancer	2.43e-05	0.000332	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—stomach cancer	2.42e-05	0.00033	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	2.39e-05	0.000326	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RHOA—stomach cancer	2.35e-05	0.000322	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—stomach cancer	2.33e-05	0.000318	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—stomach cancer	2.33e-05	0.000318	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—stomach cancer	2.28e-05	0.000311	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUN—stomach cancer	2.27e-05	0.00031	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—stomach cancer	2.27e-05	0.000309	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—stomach cancer	2.24e-05	0.000306	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	2.22e-05	0.000303	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—stomach cancer	2.21e-05	0.000302	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	2.2e-05	0.000301	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB2—stomach cancer	2.18e-05	0.000298	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—stomach cancer	2.15e-05	0.000294	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—stomach cancer	2.14e-05	0.000293	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—stomach cancer	2.08e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—stomach cancer	2.07e-05	0.000282	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—stomach cancer	2.05e-05	0.00028	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK1—stomach cancer	2.04e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—stomach cancer	2.04e-05	0.000278	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	2.02e-05	0.000276	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—stomach cancer	1.99e-05	0.000271	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—stomach cancer	1.97e-05	0.000269	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—stomach cancer	1.97e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—stomach cancer	1.93e-05	0.000263	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—stomach cancer	1.93e-05	0.000263	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUN—stomach cancer	1.92e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—stomach cancer	1.88e-05	0.000257	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—stomach cancer	1.87e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	1.86e-05	0.000254	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—stomach cancer	1.83e-05	0.00025	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—stomach cancer	1.82e-05	0.000248	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK1—stomach cancer	1.79e-05	0.000244	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—stomach cancer	1.79e-05	0.000244	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	1.77e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—stomach cancer	1.71e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—stomach cancer	1.69e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—stomach cancer	1.68e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—stomach cancer	1.66e-05	0.000227	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—stomach cancer	1.64e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—stomach cancer	1.59e-05	0.000217	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—stomach cancer	1.57e-05	0.000214	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	1.55e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—stomach cancer	1.54e-05	0.000211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK1—stomach cancer	1.51e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—stomach cancer	1.51e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—stomach cancer	1.5e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—stomach cancer	1.44e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—stomach cancer	1.43e-05	0.000195	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—stomach cancer	1.37e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	1.31e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—stomach cancer	1.27e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—stomach cancer	1.21e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—stomach cancer	1.16e-05	0.000159	CbGpPWpGaD
